Exelixis
EXEL
#1888
Rank
ยฃ8.17 B
Marketcap
ยฃ32.17
Share price
-1.75%
Change (1 day)
7.83%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company